Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling
Fabienne Gally, … , David A. Schwartz, Anthony N. Gerber
Fabienne Gally, … , David A. Schwartz, Anthony N. Gerber
Published December 15, 2020
Citation Information: JCI Insight. 2021;6(2):e144294. https://doi.org/10.1172/jci.insight.144294.
View: Text | PDF
Research Article Pulmonology

The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling

  • Text
  • PDF
Abstract

The G/T transversion rs35705950, located approximately 3 kb upstream of the MUC5B start site, is the cardinal risk factor for idiopathic pulmonary fibrosis (IPF). Here, we investigate the function and chromatin structure of this –3 kb region and provide evidence that it functions as a classically defined enhancer subject to epigenetic programming. We use nascent transcript analysis to show that RNA polymerase II loads within 10 bp of the G/T transversion site, definitively establishing enhancer function for the region. By integrating Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) analysis of fresh and cultured human airway epithelial cells with nuclease sensitivity data, we demonstrate that this region is in accessible chromatin that affects the expression of MUC5B. Through applying paired single-nucleus RNA- and ATAC-seq to frozen tissue from IPF lungs, we extend these findings directly to disease, with results indicating that epigenetic programming of the –3 kb enhancer in IPF occurs in both MUC5B-expressing and nonexpressing lineages. In aggregate, our results indicate that the MUC5B-associated variant rs35705950 resides within an enhancer that is subject to epigenetic remodeling and contributes to pathologic misexpression in IPF.

Authors

Fabienne Gally, Sarah K. Sasse, Jonathan S. Kurche, Margaret A. Gruca, Jonathan H. Cardwell, Tsukasa Okamoto, Hong W. Chu, Xiaomeng Hou, Olivier B. Poirion, Justin Buchanan, Sebastian Preissl, Bing Ren, Sean P. Colgan, Robin D. Dowell, Ivana V. Yang, David A. Schwartz, Anthony N. Gerber

×

Figure 2

PRO-seq nascent transcript profiling identifies RNAPII loading at the MUC5B G/T transversion site in A549 and LC-2/ad cells and differential transcription factor activity compared with BEAS-2B cells.

Options: View larger image (or click on image) Download as PowerPoint
PRO-seq nascent transcript profiling identifies RNAPII loading at the MU...
(A) Principal Component Analysis (PCA) of gene (top) and eRNA (bottom) transcription indicates significant separation by cell type. (B) PRO-seq data visualized in the Integrative Genomics Viewer (IGV) Genome Browser at the MUC5B locus in indicated cell types sequenced in duplicate (n = 2). Color signifies direction of RNAPII processivity (5′ to 3′, blue; 3′ to 5′, red), and vertical scales indicate counts per million mapped reads; arrow shows transcription start site and direction of transcription. Each lower panel is a progressively zoomed-in view of the MUC5B –3 kb enhancer centered on rs35705950 (purple) and its surrounding genomic sequence (bottom). (C) Motif Displacement (MD) analysis of binding motifs significantly enriched (red) or reduced (purple) in A549 (left) and LC-2/ad (right) cells relative to BEAS-2B. (D) Barcode plots depicting frequency of sequence overlap with indicated binding motifs within ± 1500 bp of eRNA origins in indicated cell types. Heat is proportional to frequency of motif instance at that distance from an eRNA origin; darker colors signify greater enrichment.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts